These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 1570153

  • 1. The severe combined immunodeficient (SCID) mouse as a model for human myeloid leukemias.
    Cesano A, Hoxie JA, Lange B, Nowell PC, Bishop J, Santoli D.
    Oncogene; 1992 May; 7(5):827-36. PubMed ID: 1570153
    [Abstract] [Full Text] [Related]

  • 2. Characterization of a novel malignant B cell line with t(14;18) and t(4;11) established from a patient with acute monoblastic leukemia.
    de Kroon JF, Kluin-Nelemans HC, Kluin PM, Schuuring E, van Bergen CA, Oving I, Wessels H, Willemze R, Falkenburg JH.
    Exp Hematol; 1997 Sep; 25(10):1062-8. PubMed ID: 9293903
    [Abstract] [Full Text] [Related]

  • 3. Growth of sensitive and drug-resistant human myeloid leukemia cells in SCID mice.
    Beran M, Pisa P, Kantarjian H, Porwit A, Bjorkholm M.
    Hematol Pathol; 1994 Sep; 8(4):135-54. PubMed ID: 7860433
    [Abstract] [Full Text] [Related]

  • 4. Antileukemia activity of a natural killer cell line against human leukemias.
    Yan Y, Steinherz P, Klingemann HG, Dennig D, Childs BH, McGuirk J, O'Reilly RJ.
    Clin Cancer Res; 1998 Nov; 4(11):2859-68. PubMed ID: 9829753
    [Abstract] [Full Text] [Related]

  • 5. Good engraftment of B-cell precursor ALL in NOD-SCID mice.
    Baersch G, Möllers T, Hötte A, Dockhorn-Dworniczak B, Rübe C, Ritter J, Jürgens H, Vormoor J.
    Klin Padiatr; 1997 Nov; 209(4):178-85. PubMed ID: 9293448
    [Abstract] [Full Text] [Related]

  • 6. Establishment of an in vivo human myeloid leukemia model in the SCID mouse.
    Arai C, Tsuzaki Y, Arai N, Takeuchi M, Kurimoto M, Nagano Y.
    In Vivo; 1999 Nov; 13(1):35-40. PubMed ID: 10218130
    [Abstract] [Full Text] [Related]

  • 7. Human myeloid and lymphoid malignancies in the non-obese diabetic/severe combined immunodeficiency mouse model: frequency of apoptotic cells in solid tumors and efficiency and speed of engraftment correlate with vascular endothelial growth factor production.
    Fusetti L, Pruneri G, Gobbi A, Rabascio C, Carboni N, Peccatori F, Martinelli G, Bertolini F.
    Cancer Res; 2000 May 01; 60(9):2527-34. PubMed ID: 10811135
    [Abstract] [Full Text] [Related]

  • 8. Role of granulocyte-macrophage colony-stimulating factor in Philadelphia (Ph1)-positive acute lymphoblastic leukemia: studies on two newly established Ph1-positive acute lymphoblastic leukemia cell lines (Z-119 and Z-181).
    Estrov Z, Talpaz M, Zipf TF, Kantarjian HM, Ku S, Ouspenskaia MV, Hirsch-Ginsberg C, Huh Y, Yee G, Kurzrock R.
    J Cell Physiol; 1996 Mar 01; 166(3):618-30. PubMed ID: 8600166
    [Abstract] [Full Text] [Related]

  • 9. Development of a severe combined immunodeficiency (SCID) mouse model consisting of highly disseminated human B-cell leukemia/lymphoma, cure of the tumors by systemic administration of immunotoxin, and development/application of a clonotype-specific polymerase chain reaction-based assay.
    Yoshida M, Rybak RJ, Choi Y, Greenberg SJ, Barcos M, Kawata A, Matsuno F, Tsai H, Seon BK.
    Cancer Res; 1997 Feb 15; 57(4):678-85. PubMed ID: 9044845
    [Abstract] [Full Text] [Related]

  • 10. Differential growth patterns in SCID mice of patient-derived chronic myelogenous leukemias.
    McGuirk J, Yan Y, Childs B, Fernandez J, Barnett L, Jagiello C, Collins N, O'Reilly RJ.
    Bone Marrow Transplant; 1998 Aug 15; 22(4):367-74. PubMed ID: 9722072
    [Abstract] [Full Text] [Related]

  • 11. IL-2Ralpha-Directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Ralpha interaction.
    Phillips KE, Herring B, Wilson LA, Rickford MS, Zhang M, Goldman CK, Tso JY, Waldmann TA.
    Cancer Res; 2000 Dec 15; 60(24):6977-84. PubMed ID: 11156399
    [Abstract] [Full Text] [Related]

  • 12. Biological properties and growth in SCID mice of a new myelogenous leukemia cell line (KBM-5) derived from chronic myelogenous leukemia cells in the blastic phase.
    Beran M, Pisa P, O'Brien S, Kurzrock R, Siciliano M, Cork A, Andersson BS, Kohli V, Kantarjian H.
    Cancer Res; 1993 Aug 01; 53(15):3603-10. PubMed ID: 8339266
    [Abstract] [Full Text] [Related]

  • 13. Propagation of human blastic myeloid leukemias in the SCID mouse.
    Sawyers CL, Gishizky ML, Quan S, Golde DW, Witte ON.
    Blood; 1992 Apr 15; 79(8):2089-98. PubMed ID: 1562735
    [Abstract] [Full Text] [Related]

  • 14. Retrospective analysis of ras gene activation in myeloid leukemic cells.
    Lübbert M, Jonas D, Miller CW, Herrmann F, Mertelsmann R, McCormick F, Koeffler HP.
    Oncogene; 1990 Apr 15; 5(4):583-7. PubMed ID: 2183160
    [Abstract] [Full Text] [Related]

  • 15. Severe combined immunodeficient-hu model of human prostate cancer metastasis to human bone.
    Nemeth JA, Harb JF, Barroso U, He Z, Grignon DJ, Cher ML.
    Cancer Res; 1999 Apr 15; 59(8):1987-93. PubMed ID: 10213511
    [Abstract] [Full Text] [Related]

  • 16. IMC-EB10, an anti-FLT3 monoclonal antibody, prolongs survival and reduces nonobese diabetic/severe combined immunodeficient engraftment of some acute lymphoblastic leukemia cell lines and primary leukemic samples.
    Piloto O, Nguyen B, Huso D, Kim KT, Li Y, Witte L, Hicklin DJ, Brown P, Small D.
    Cancer Res; 2006 May 01; 66(9):4843-51. PubMed ID: 16651440
    [Abstract] [Full Text] [Related]

  • 17. In vivo therapeutic effects of IFN-gamma on human myelogenous leukemia in a severe combined immunodeficiency mouse model.
    Arai C, Tsuzaki Y, Nagano Y.
    In Vivo; 1999 May 01; 13(6):445-51. PubMed ID: 10757035
    [Abstract] [Full Text] [Related]

  • 18. Establishment of new SCID and nude mouse models of human B leukemia/lymphoma and effective therapy of the tumors with immunotoxin and monoclonal antibody: marked difference between the SCID and nude mouse models in the antitumor efficacy of monoclonal antibody.
    Kawata A, Yoshida M, Okazaki M, Yokota S, Barcos M, Seon BK.
    Cancer Res; 1994 May 15; 54(10):2688-94. PubMed ID: 8168098
    [Abstract] [Full Text] [Related]

  • 19. Engraftment of human T-cell acute lymphoblastic leukemia in immunodeficient NOD/SCID mice which have been preconditioned by injection of human cord blood.
    Dialynas DP, Shao L, Billman GF, Yu J.
    Stem Cells; 2001 May 15; 19(5):443-52. PubMed ID: 11553853
    [Abstract] [Full Text] [Related]

  • 20. In vitro growth characteristics of virally transformed murine myeloid cells.
    Nooter K, Bentvelzen P.
    Cancer Res; 1976 Apr 15; 36(4):1246-50. PubMed ID: 177204
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.